tiprankstipranks
Roche receives CE Mark for Ventana FOLR1 RxDx Assay
PremiumThe FlyRoche receives CE Mark for Ventana FOLR1 RxDx Assay
8d ago
Genentech terminates agreement for Nykode cancer vaccine program
Premium
The Fly
Genentech terminates agreement for Nykode cancer vaccine program
18d ago
Genentech to present blood disorders data at ASH
Premium
The Fly
Genentech to present blood disorders data at ASH
21d ago
Roche sees 2024 core EPS growing in high single digit range
PremiumThe FlyRoche sees 2024 core EPS growing in high single digit range
1M ago
Voyager Therapeutics selloff on UCB news ‘excessive,’ says Leerink
Premium
The Fly
Voyager Therapeutics selloff on UCB news ‘excessive,’ says Leerink
1M ago
Genentech announces topline one-year results from ELEVATUM study
Premium
The Fly
Genentech announces topline one-year results from ELEVATUM study
1M ago
FDA Approves Genentech’s Itovebi in HER2-negative breast cancer
PremiumThe FlyFDA Approves Genentech’s Itovebi in HER2-negative breast cancer
2M ago
FDA approves Roche’s inavolisib combo for metastatic breast cancer
Premium
The Fly
FDA approves Roche’s inavolisib combo for metastatic breast cancer
2M ago
Tempest Therapeutics announces agreement with Roche for amezalpat combo therapy
Premium
The Fly
Tempest Therapeutics announces agreement with Roche for amezalpat combo therapy
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100